Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2010
12/29/2010WO2010151710A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
12/29/2010WO2010151611A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010WO2010151524A1 Solid states forms of varenicline salts and processes for preparation thereof
12/29/2010WO2010150840A1 N-substituted-cyclic amino derivative
12/29/2010WO2010150281A2 Novel azabicyclohexanes
12/29/2010WO2010150276A2 Process for preparing sulphoxide compounds
12/29/2010WO2010150204A1 N-(2-oxo-1-phenylpiperidin-3-yl) sulfonamides for the identification of biological and pharmacological activity
12/29/2010WO2010149956A1 4 -aminopicolinates and their use as herbicides
12/29/2010WO2010149685A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149684A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149634A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists
12/29/2010WO2010149541A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/29/2010WO2010149506A1 Insecticidal compounds
12/29/2010WO2010149044A1 Micromolecular benzotriazine compounds, compositions and uses thereof
12/29/2010WO2010148631A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010WO2010063996A3 Antibacterial compounds
12/29/2010WO2010004571A3 Process for purification of rabeprazole sodium
12/29/2010EP2266974A1 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-Quinolin-2-one lactic acid salts
12/29/2010EP2266973A1 Pyrazinylpyrazole
12/29/2010EP2266972A1 New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies
12/29/2010EP2266971A2 Hiv protease inhibiting compounds
12/29/2010EP2266970A1 Substituted aromatic heterocyclic compounds as fungicides
12/29/2010EP2266969A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/29/2010EP2266958A1 Antiviral agent
12/29/2010EP2266566A2 Nicotinamide derivatives and their use as therapeutic agents
12/29/2010EP2265605A1 Dexlansoprazole process and polymorphs
12/29/2010EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
12/29/2010EP2265601A1 Pyridazine derivatives as factor xia inhibitors
12/29/2010EP2265600A1 Pyridinyl amides for the treatment of cns and metabolic disorders
12/29/2010EP2265599A2 Crystal form of phenylamino pyrimidine derivative
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265597A2 Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole)
12/29/2010EP2265592A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
12/29/2010EP2265587A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/29/2010EP2265582A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof.
12/29/2010EP2265578A1 Azetidine derivatives
12/29/2010EP2265575A2 Sulfonamides
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265273A1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP2265119A1 Fungicide hydroximoyl-tetrazole derivatives
12/29/2010EP2265118A2 Fungicide hydroximoyl-tetrazole derivatives
12/29/2010EP2142527B1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/29/2010EP2049519B9 Cyclic derivatives as modulators of chemokine receptor activity
12/29/2010EP2010514B1 3-(pyridin-2-yl)-[1,2,4]-triazines for use as fungicides
12/29/2010EP1943243B1 Kinase inhibitors
12/29/2010EP1940826B1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1857453B1 Fluoroalkylpyrrolidine derivatives
12/29/2010EP1809620B1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1758578B1 Novel indazole carboxamides and their use
12/29/2010EP1717237B1 Anthranilamides, process for the production thereof, and pest controllers containing the same
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1487802B1 2,3-Diaryl-pyrazolidine derivatives as neurotensin degrading enzyme inhibitors
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN101932573A Novel pyridinones and pyridazinones
12/29/2010CN101932572A Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
12/29/2010CN101932571A Compounds having crth2 antagonist activity
12/29/2010CN101932570A Trpv1 antagonists and uses thereof
12/29/2010CN101932569A Indoles, derivatives, and analogs thereof and uses therefor
12/29/2010CN101932562A Carbamoyl compounds as dgat1 inhibitors 190
12/29/2010CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101928278A (S)-4-[(4-chlorphenyl)(pyridine-2-yl)methoxyl]piperidinehydroxyphenpropionate and application thereof
12/29/2010CN101928277A Preparation method of 4-methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzoic acid, related intermediate and application thereof
12/29/2010CN101503392B Aromatic aminomethane compounds, as well as preparation and medical use thereof
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2781865A1 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
12/29/2010CA2766696A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010CA2766550A1 Benzamide derivatives
12/29/2010CA2766154A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010CA2766033A1 Prodrugs of nh-acidic compounds
12/29/2010CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/29/2010CA2765817A1 Heterocyclic compounds and their uses
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/29/2010CA2764422A1 Insecticidal compounds
12/29/2010CA2764200A1 4 -aminopicolinates and their use as herbicides
12/29/2010CA2761921A1 Novel indole, indazole and benzimidazole arylamides
12/29/2010CA2754654A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858808 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
12/28/2010US7858800 Biaryl derivatives
12/28/2010US7858799 Gelling agent, carbon nanotubes aqueous dispersing agent; simple synthesis from low cost, readily available raw materials; rapid elastic modulus recovery; environmentally friendly
12/28/2010US7858797 Biphenyl compounds useful as muscarinic receptor antagonists
12/28/2010US7858796 novel indole carboxamide derivatives for inflammatory and tissue repair disorders like rheumatoid arthritis, asthma, and COPD; kinase inhibitors in particular IKK2; 3-{1-[(2-aminoethyl)sulfonyl]-4-piperidinyl}-5-phenyl-1H-indole-7-carboxamide
12/28/2010US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis
12/28/2010US7858792 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
12/28/2010US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
12/28/2010US7858786 Pyrimidines and pyrazines useful as modulators of ion channels
12/28/2010US7858782 e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858646 1-(2-hydroxy-3-methyl-4-{4-[4-(1H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-phenyl)-ethanone; 6-(3-((4-acetyl-3-hydroxy-2-propylphenoxy)methyl)phenylthio)isonicotinic acid; 1-(2-hydroxy-4-{3-[4-(2H-tetrazol-5-yl)-pyridin-2-yloxy]-benzyloxy}-3-trifluoromethyl-phenyl)-ethanone; treatment of migriane
12/28/2010US7858645 Indazole derivatives
12/28/2010US7858643 Crizotinib, a c-Met protein kinase inhibitor anticancer agent; 3-[(R)-1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine is crizotinib